ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global N-Methylcaprolactam Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-0D17645
Home | Market Reports | Business & Industrial| Chemicals Industry
Global N Methylcaprolactam Market Research Report 2024
BUY CHAPTERS

Global N-Methylcaprolactam Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0D17645
Report
October 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aagami, Inc.
Zhejiang Kinso Pharmaceuticals
Linkchem
DOMO Caproleuna GmbH
Suzhou Guide Fine Materials

N-Methylcaprolactam Market

The global N-Methylcaprolactam market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Organic Synthesis Intermediates accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
N-Methylcaprolactam leading manufacturers including Aagami, Inc., DOMO Caproleuna GmbH, Zhejiang Kinso Pharmaceuticals, LinkChem, Suzhou Guide Fine Materials, etc., dominate supply; the top five capture approximately % of global revenue, with Aagami, Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global N-Methylcaprolactam market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of N-Methylcaprolactam Market Report

Report Metric Details
Report Name N-Methylcaprolactam Market
Segment by Type
  • Purity 98%
  • Purity 95%
  • Others
Segment by Application
  • Organic Synthesis Intermediates
  • Pharmaceutical Intermediates
  • Others
Production by Region
  • North America
  • Europe
  • China
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aagami, Inc., DOMO Caproleuna GmbH, Zhejiang Kinso Pharmaceuticals, LinkChem, Suzhou Guide Fine Materials
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the N-Methylcaprolactam study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the N-Methylcaprolactam Market report?

Ans: The main players in the N-Methylcaprolactam Market are Aagami, Inc., DOMO Caproleuna GmbH, Zhejiang Kinso Pharmaceuticals, LinkChem, Suzhou Guide Fine Materials

What are the Application segmentation covered in the N-Methylcaprolactam Market report?

Ans: The Applications covered in the N-Methylcaprolactam Market report are Organic Synthesis Intermediates, Pharmaceutical Intermediates, Others

What are the Type segmentation covered in the N-Methylcaprolactam Market report?

Ans: The Types covered in the N-Methylcaprolactam Market report are Purity 98%, Purity 95%, Others

1 Study Coverage
1.1 Introduction to N-Methylcaprolactam: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global N-Methylcaprolactam Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity 98%
1.2.3 Purity 95%
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global N-Methylcaprolactam Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Organic Synthesis Intermediates
1.3.3 Pharmaceutical Intermediates
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global N-Methylcaprolactam Revenue Estimates and Forecasts 2020-2031
2.2 Global N-Methylcaprolactam Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global N-Methylcaprolactam Sales Estimates and Forecasts 2020-2031
2.4 Global N-Methylcaprolactam Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global N-Methylcaprolactam Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
4 Competition by Manufacturers
4.1 Global N-Methylcaprolactam Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global N-Methylcaprolactam Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity 98% Market Size by Manufacturers
4.5.2 Purity 95% Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global N-Methylcaprolactam Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global N-Methylcaprolactam Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global N-Methylcaprolactam Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global N-Methylcaprolactam Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global N-Methylcaprolactam Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America N-Methylcaprolactam Sales and Revenue by Type (2020-2031)
7.4 North America N-Methylcaprolactam Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America N-Methylcaprolactam Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe N-Methylcaprolactam Sales and Revenue by Type (2020-2031)
8.4 Europe N-Methylcaprolactam Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe N-Methylcaprolactam Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific N-Methylcaprolactam Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific N-Methylcaprolactam Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific N-Methylcaprolactam Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America N-Methylcaprolactam Sales and Revenue by Type (2020-2031)
10.4 Central and South America N-Methylcaprolactam Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America N-Methylcaprolactam Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa N-Methylcaprolactam Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa N-Methylcaprolactam Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa N-Methylcaprolactam Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Aagami, Inc.
12.1.1 Aagami, Inc. Corporation Information
12.1.2 Aagami, Inc. Business Overview
12.1.3 Aagami, Inc. N-Methylcaprolactam Product Models, Descriptions and Specifications
12.1.4 Aagami, Inc. N-Methylcaprolactam Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Aagami, Inc. N-Methylcaprolactam Sales by Product in 2024
12.1.6 Aagami, Inc. N-Methylcaprolactam Sales by Application in 2024
12.1.7 Aagami, Inc. N-Methylcaprolactam Sales by Geographic Area in 2024
12.1.8 Aagami, Inc. N-Methylcaprolactam SWOT Analysis
12.1.9 Aagami, Inc. Recent Developments
12.2 DOMO Caproleuna GmbH
12.2.1 DOMO Caproleuna GmbH Corporation Information
12.2.2 DOMO Caproleuna GmbH Business Overview
12.2.3 DOMO Caproleuna GmbH N-Methylcaprolactam Product Models, Descriptions and Specifications
12.2.4 DOMO Caproleuna GmbH N-Methylcaprolactam Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 DOMO Caproleuna GmbH N-Methylcaprolactam Sales by Product in 2024
12.2.6 DOMO Caproleuna GmbH N-Methylcaprolactam Sales by Application in 2024
12.2.7 DOMO Caproleuna GmbH N-Methylcaprolactam Sales by Geographic Area in 2024
12.2.8 DOMO Caproleuna GmbH N-Methylcaprolactam SWOT Analysis
12.2.9 DOMO Caproleuna GmbH Recent Developments
12.3 Zhejiang Kinso Pharmaceuticals
12.3.1 Zhejiang Kinso Pharmaceuticals Corporation Information
12.3.2 Zhejiang Kinso Pharmaceuticals Business Overview
12.3.3 Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam Product Models, Descriptions and Specifications
12.3.4 Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam Sales by Product in 2024
12.3.6 Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam Sales by Application in 2024
12.3.7 Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam Sales by Geographic Area in 2024
12.3.8 Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam SWOT Analysis
12.3.9 Zhejiang Kinso Pharmaceuticals Recent Developments
12.4 LinkChem
12.4.1 LinkChem Corporation Information
12.4.2 LinkChem Business Overview
12.4.3 LinkChem N-Methylcaprolactam Product Models, Descriptions and Specifications
12.4.4 LinkChem N-Methylcaprolactam Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 LinkChem N-Methylcaprolactam Sales by Product in 2024
12.4.6 LinkChem N-Methylcaprolactam Sales by Application in 2024
12.4.7 LinkChem N-Methylcaprolactam Sales by Geographic Area in 2024
12.4.8 LinkChem N-Methylcaprolactam SWOT Analysis
12.4.9 LinkChem Recent Developments
12.5 Suzhou Guide Fine Materials
12.5.1 Suzhou Guide Fine Materials Corporation Information
12.5.2 Suzhou Guide Fine Materials Business Overview
12.5.3 Suzhou Guide Fine Materials N-Methylcaprolactam Product Models, Descriptions and Specifications
12.5.4 Suzhou Guide Fine Materials N-Methylcaprolactam Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Suzhou Guide Fine Materials N-Methylcaprolactam Sales by Product in 2024
12.5.6 Suzhou Guide Fine Materials N-Methylcaprolactam Sales by Application in 2024
12.5.7 Suzhou Guide Fine Materials N-Methylcaprolactam Sales by Geographic Area in 2024
12.5.8 Suzhou Guide Fine Materials N-Methylcaprolactam SWOT Analysis
12.5.9 Suzhou Guide Fine Materials Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 N-Methylcaprolactam Industry Chain
13.2 N-Methylcaprolactam Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 N-Methylcaprolactam Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 N-Methylcaprolactam Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 N-Methylcaprolactam Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global N-Methylcaprolactam Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Aagami, Inc.
Zhejiang Kinso Pharmaceuticals
Linkchem
DOMO Caproleuna GmbH
Suzhou Guide Fine Materials
List of Tables
 Table 1. Global N-Methylcaprolactam Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global N-Methylcaprolactam Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global N-Methylcaprolactam Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global N-Methylcaprolactam Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global N-Methylcaprolactam Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global N-Methylcaprolactam Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global N-Methylcaprolactam Sales by Region (2020-2025) & (Tons)
 Table 8. Global N-Methylcaprolactam Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global N-Methylcaprolactam Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global N-Methylcaprolactam Production by Region (2020-2025) & (Tons)
 Table 12. Global N-Methylcaprolactam Production by Region (2026-2031) & (Tons)
 Table 13. Global N-Methylcaprolactam Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global N-Methylcaprolactam Sales Share by Manufacturers (2020-2025)
 Table 15. Global N-Methylcaprolactam Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global N-Methylcaprolactam Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global N-Methylcaprolactam by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-Methylcaprolactam as of 2024)
 Table 19. Global N-Methylcaprolactam Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global N-Methylcaprolactam Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers N-Methylcaprolactam Manufacturing Base and Headquarters
 Table 22. Global N-Methylcaprolactam Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global N-Methylcaprolactam Sales by Type (2020-2025) & (Tons)
 Table 26. Global N-Methylcaprolactam Sales by Type (2026-2031) & (Tons)
 Table 27. Global N-Methylcaprolactam Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global N-Methylcaprolactam Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global N-Methylcaprolactam ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global N-Methylcaprolactam Sales by Application (2020-2025) & (Tons)
 Table 32. Global N-Methylcaprolactam Sales by Application (2026-2031) & (Tons)
 Table 33. N-Methylcaprolactam High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global N-Methylcaprolactam Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global N-Methylcaprolactam Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global N-Methylcaprolactam ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America N-Methylcaprolactam Growth Accelerators and Market Barriers
 Table 40. North America N-Methylcaprolactam Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America N-Methylcaprolactam Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe N-Methylcaprolactam Growth Accelerators and Market Barriers
 Table 43. Europe N-Methylcaprolactam Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe N-Methylcaprolactam Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific N-Methylcaprolactam Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific N-Methylcaprolactam Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific N-Methylcaprolactam Growth Accelerators and Market Barriers
 Table 48. Southeast Asia N-Methylcaprolactam Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America N-Methylcaprolactam Investment Opportunities and Key Challenges
 Table 50. Central and South America N-Methylcaprolactam Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa N-Methylcaprolactam Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa N-Methylcaprolactam Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Aagami, Inc. Corporation Information
 Table 54. Aagami, Inc. Description and Major Businesses
 Table 55. Aagami, Inc. Product Models, Descriptions and Specifications
 Table 56. Aagami, Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Aagami, Inc. Sales Value Proportion by Product in 2024
 Table 58. Aagami, Inc. Sales Value Proportion by Application in 2024
 Table 59. Aagami, Inc. Sales Value Proportion by Geographic Area in 2024
 Table 60. Aagami, Inc. N-Methylcaprolactam SWOT Analysis
 Table 61. Aagami, Inc. Recent Developments
 Table 62. DOMO Caproleuna GmbH Corporation Information
 Table 63. DOMO Caproleuna GmbH Description and Major Businesses
 Table 64. DOMO Caproleuna GmbH Product Models, Descriptions and Specifications
 Table 65. DOMO Caproleuna GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. DOMO Caproleuna GmbH Sales Value Proportion by Product in 2024
 Table 67. DOMO Caproleuna GmbH Sales Value Proportion by Application in 2024
 Table 68. DOMO Caproleuna GmbH Sales Value Proportion by Geographic Area in 2024
 Table 69. DOMO Caproleuna GmbH N-Methylcaprolactam SWOT Analysis
 Table 70. DOMO Caproleuna GmbH Recent Developments
 Table 71. Zhejiang Kinso Pharmaceuticals Corporation Information
 Table 72. Zhejiang Kinso Pharmaceuticals Description and Major Businesses
 Table 73. Zhejiang Kinso Pharmaceuticals Product Models, Descriptions and Specifications
 Table 74. Zhejiang Kinso Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Zhejiang Kinso Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 76. Zhejiang Kinso Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 77. Zhejiang Kinso Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 78. Zhejiang Kinso Pharmaceuticals N-Methylcaprolactam SWOT Analysis
 Table 79. Zhejiang Kinso Pharmaceuticals Recent Developments
 Table 80. LinkChem Corporation Information
 Table 81. LinkChem Description and Major Businesses
 Table 82. LinkChem Product Models, Descriptions and Specifications
 Table 83. LinkChem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. LinkChem Sales Value Proportion by Product in 2024
 Table 85. LinkChem Sales Value Proportion by Application in 2024
 Table 86. LinkChem Sales Value Proportion by Geographic Area in 2024
 Table 87. LinkChem N-Methylcaprolactam SWOT Analysis
 Table 88. LinkChem Recent Developments
 Table 89. Suzhou Guide Fine Materials Corporation Information
 Table 90. Suzhou Guide Fine Materials Description and Major Businesses
 Table 91. Suzhou Guide Fine Materials Product Models, Descriptions and Specifications
 Table 92. Suzhou Guide Fine Materials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Suzhou Guide Fine Materials Sales Value Proportion by Product in 2024
 Table 94. Suzhou Guide Fine Materials Sales Value Proportion by Application in 2024
 Table 95. Suzhou Guide Fine Materials Sales Value Proportion by Geographic Area in 2024
 Table 96. Suzhou Guide Fine Materials N-Methylcaprolactam SWOT Analysis
 Table 97. Suzhou Guide Fine Materials Recent Developments
 Table 98. Key Raw Materials Distribution
 Table 99. Raw Materials Key Suppliers
 Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 101. Milestones in Production Technology Evolution
 Table 102. Distributors List
 Table 103. Market Trends and Market Evolution
 Table 104. Market Drivers and Opportunities
 Table 105. Market Challenges, Risks, and Restraints
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. N-Methylcaprolactam Product Picture
 Figure 2. Global N-Methylcaprolactam Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity 98% Product Picture
 Figure 4. Purity 95% Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global N-Methylcaprolactam Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Organic Synthesis Intermediates
 Figure 8. Pharmaceutical Intermediates
 Figure 9. Others
 Figure 10. N-Methylcaprolactam Report Years Considered
 Figure 11. Global N-Methylcaprolactam Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 13. Global N-Methylcaprolactam Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global N-Methylcaprolactam Revenue Market Share by Region (2020-2031)
 Figure 15. Global N-Methylcaprolactam Sales (2020-2031) & (Tons)
 Figure 16. Global N-Methylcaprolactam Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global N-Methylcaprolactam Sales Market Share by Region (2020-2031)
 Figure 18. Global N-Methylcaprolactam Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global N-Methylcaprolactam Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global N-Methylcaprolactam Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. N-Methylcaprolactam Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. N-Methylcaprolactam Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. N-Methylcaprolactam Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers N-Methylcaprolactam Sales Volume Market Share in 2024
 Figure 26. Global N-Methylcaprolactam Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Purity 98% Revenue Market Share by Manufacturer in 2024
 Figure 29. Purity 95% Revenue Market Share by Manufacturer in 2024
 Figure 30. Others Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global N-Methylcaprolactam Sales Market Share by Type (2020-2031)
 Figure 34. Global N-Methylcaprolactam Revenue Market Share by Type (2020-2031)
 Figure 35. Global N-Methylcaprolactam Sales Market Share by Application (2020-2031)
 Figure 36. Global N-Methylcaprolactam Revenue Market Share by Application (2020-2031)
 Figure 37. North America N-Methylcaprolactam Sales YoY (2020-2031) & (Tons)
 Figure 38. North America N-Methylcaprolactam Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers N-Methylcaprolactam Sales Revenue (US$ Million) in 2024
 Figure 40. North America N-Methylcaprolactam Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America N-Methylcaprolactam Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America N-Methylcaprolactam Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America N-Methylcaprolactam Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe N-Methylcaprolactam Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe N-Methylcaprolactam Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers N-Methylcaprolactam Sales Revenue (US$ Million) in 2024
 Figure 50. Europe N-Methylcaprolactam Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe N-Methylcaprolactam Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe N-Methylcaprolactam Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe N-Methylcaprolactam Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 55. France N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific N-Methylcaprolactam Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific N-Methylcaprolactam Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers N-Methylcaprolactam Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific N-Methylcaprolactam Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific N-Methylcaprolactam Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific N-Methylcaprolactam Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific N-Methylcaprolactam Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 70. India N-Methylcaprolactam Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America N-Methylcaprolactam Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America N-Methylcaprolactam Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers N-Methylcaprolactam Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America N-Methylcaprolactam Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America N-Methylcaprolactam Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America N-Methylcaprolactam Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America N-Methylcaprolactam Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil N-Methylcaprolactam Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina N-Methylcaprolactam Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa N-Methylcaprolactam Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa N-Methylcaprolactam Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers N-Methylcaprolactam Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa N-Methylcaprolactam Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America N-Methylcaprolactam Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa N-Methylcaprolactam Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa N-Methylcaprolactam Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries N-Methylcaprolactam Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey N-Methylcaprolactam Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt N-Methylcaprolactam Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa N-Methylcaprolactam Revenue (2020-2025) & (US$ Million)
 Figure 91. N-Methylcaprolactam Industry Chain Mapping
 Figure 92. Regional N-Methylcaprolactam Manufacturing Base Distribution (%)
 Figure 93. N-Methylcaprolactam Production Process
 Figure 94. Regional N-Methylcaprolactam Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global N Vinyl caprolactam Market Research Report 2025
Global N Methylethanolamine Market Research Report 2025
Global N Vinyl N Methylacetamide Market Research Report 2025
Global N Methyl 1 Naphthylmethylamine Market Research Report 2025
Global N methylbenzylamine Market Research Report 2025
Global Methyl Caprate Market Research Report 2025
Global n Amyl Methyl Ketone Market Research Report 2025
Global N methyl Indole Market Research Report 2025
Global Methyl Triflate Market Research Report 2024
Global Methylcellulose Market Research Report 2024
Global N N Dimethyloctadecylamine Market Research Report 2024
Global Methyl Caproate Methyl Hexanoate Market Research Report 2025
Global Methyl Palmitate Market Research Report 2024
Global N Decanoyl N methylglucamine Market Research Report 2025
Global Ammonium Sulphate Caprolactam Grade Market Research Report 2025
Global Methyl Butyrate Market Research Report 2024
Global Methylene Urea Market Research Report 2025
Global N N Dimethylacrylamide Market Research Report 2024
Global Industrial Grade N vinyl Caprolactam NVC Market Research Report 2025
Global Methyl Pamplemousse Market Research Report 2024

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions